4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000200
Director sold 30,000 shares at $29.03 ($870,900)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Krognes Steve E. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-09-30 | Sale : show line 1 in the form 10b5-1 | −30,000 | $29.03 | $870,900 | 29,096 | D |
| Open-market sales · 30,000 sh · avg $29.03 · $870,900 | ||||||
Loading xslF345X05/wk-form4_1727901447.xml…